In 3xTg-AD mice IVIG treatment had no effect on plaque deposition or insoluble Aβ, although it decreased 56 kDa Aβ oligomers by 60%, and no influence on tau pathology [55]. This evidence concerns the gene MAPT and Alzheimer disease.